What is Leerink Partnrs’ Forecast for Veracyte Q2 Earnings?
Veracyte, Inc. (NASDAQ:VCYT – Free Report) – Research analysts at Leerink Partnrs reduced their Q2 2025 earnings estimates for shares of Veracyte in a research note issued to investors on Monday, April 21st. Leerink Partnrs analyst P. Souda now expects that the biotechnology company will earn $0.24 per share for the quarter, down from their […]
Veracyte, Inc. (NASDAQ:VCYT – Free Report) – Research analysts at Leerink Partnrs reduced their Q2 2025 earnings estimates for shares of Veracyte in a research note issued to investors on Monday, April 21st. Leerink Partnrs analyst P. Souda now expects that the biotechnology company will earn $0.24 per share for the quarter, down from their […]